Virus

Could engineered red blood cells be an effective antiviral against SARS-CoV-2?

Anti-SARS-CoV-2 antibodies administered by NTD protect against lethal infection

The reopening of college campuses could trigger the mass release of COVID-19

Common oral fertilizers have been found to inhibit SARS-CoV-2 in vitro

SARS-CoV-2 infection increases risk of COVID-19 infection in pregnant women, newborns

A study includes a novel gene for the deaf

The latest research shows immunity to COVID-19 lasts at least 8 months

Middle-cell immunity may be more important than neutralizing antibodies in COVID-19 production

Researchers are developing a prototype harmless air sterilization to kill microbes

Early clinical data indicate the efficacy of the existing drug in the treatment of COVID-19